These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 16200918

  • 1. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J, Taboada M, Rodríguez J, Caruezo V, Bouzada M, Campaña O, Bascuas B, Pérez-Paz J, Ginesta V.
    Rev Esp Anestesiol Reanim; 2005; 52(7):389-94. PubMed ID: 16200918
    [Abstract] [Full Text] [Related]

  • 2. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 3. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
    Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, Ginesta V, Rubio J, García-Bengoechea JB, González-Juanatey JR.
    Rev Esp Cardiol; 2006 Apr; 59(4):338-45. PubMed ID: 16709386
    [Abstract] [Full Text] [Related]

  • 4. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
    Alvarez J, Baluja A, Selas S, Otero P, Rial M, Veiras S, Caruezo V, Taboada M, Rodriguez I, Castroagudin J, Tome S, Rodriguez A, Rodriguez J.
    Anaesth Intensive Care; 2013 Nov; 41(6):719-27. PubMed ID: 24180712
    [Abstract] [Full Text] [Related]

  • 5. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
    Cunha-Goncalves D, Perez-de-Sa V, Larsson A, Thörne J, Blomquist S.
    Anesth Analg; 2009 Nov; 109(5):1576-83. PubMed ID: 19713252
    [Abstract] [Full Text] [Related]

  • 6. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis.
    Gandham R, Syamasundar A, Ravulapalli H, Karthekeyan RB, Vakamudi M, Kodalli R, Nandipati S.
    Ann Card Anaesth; 2013 Nov; 16(1):11-5. PubMed ID: 23287080
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM.
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [Abstract] [Full Text] [Related]

  • 8. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
    Bragadottir G, Redfors B, Ricksten SE.
    Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
    [Abstract] [Full Text] [Related]

  • 9. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D, Perez-de-Sa V, Grins E, Dahm PL, Thörne J, Blomquist S.
    Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
    Russ MA, Prondzinsky R, Christoph A, Schlitt A, Buerke U, Söffker G, Lemm H, Swyter M, Wegener N, Winkler M, Carter JM, Reith S, Werdan K, Buerke M.
    Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B.
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
    [Abstract] [Full Text] [Related]

  • 13. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 14. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P.
    Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
    [Abstract] [Full Text] [Related]

  • 15. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
    Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, Tanus E, del Mazo CD.
    Rev Esp Cardiol; 2008 May; 61(5):471-9. PubMed ID: 18462650
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabrò MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group.
    N Engl J Med; 2017 May 25; 376(21):2021-2031. PubMed ID: 28320259
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.
    Eur J Anaesthesiol; 2008 Aug 25; 25(8):627-33. PubMed ID: 18405408
    [Abstract] [Full Text] [Related]

  • 18. Levosimendan: a review of its use in the management of acute decompensated heart failure.
    Innes CA, Wagstaff AJ.
    Drugs; 2003 Aug 25; 63(23):2651-71. PubMed ID: 14636085
    [Abstract] [Full Text] [Related]

  • 19. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA, Marsh KC, Polakowski JS, Fryer RM.
    J Pharmacol Exp Ther; 2008 Apr 25; 325(1):331-40. PubMed ID: 18171907
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study.
    Lancet; 2002 Jul 20; 360(9328):196-202. PubMed ID: 12133653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.